Search Results - "O'Rorke, Michael"

Making progress against rare cancers: A case study on neuroendocrine tumors by O’Rorke, Michael, Chrischilles, Elizabeth, Chamberlain, Alanna M., Chrischilles, Elizabeth A., Cowell, Lindsay G., Dillon, Joseph S., Early, Carol, Else, Tobias, Gamblin, T. Clark, Geller, David, Gellerman, Elyse, Gryzlak, Brian, Halfdanarson, Thorvardur R., Hamilton, Harley C., He, Fiona C., Hourcade, Juan Pablo, Indrees, Kamran, Kazmi, Syed M., Lancaster, William, Lewis‐Hughes, Amoni, Liu, Mei, Mailman, Josh A., McDowell, Bradley, O’Rorke, Michael, Ramirez, Robert A., Ramnaraign, Brian H., Sanoff, Hanna K., Soares, Heloisa P., Sukrithan, Vineeth, Taylor, Bradley W., Tepper, Mia S., Wahmann, Maryann, Zamba, Gideon K. D.

“…In April 2023, the National Cancer Institute offered a roadmap for cancer research to achieve Cancer Moonshot goals. To reach these goals requires making…”
Get full text

How common are myeloproliferative neoplasms? A systematic review and meta‐analysis by Titmarsh, Glen J., Duncombe, Andrew S., McMullin, Mary Frances, O'Rorke, Michael, Mesa, Ruben, Vocht, Frank, Horan, Sarah, Fritschi, Lin, Clarke, Mike, Anderson, Lesley A.

“…Myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases including polycythemia vera (PV), essential thrombocythemia (ET), and…”
Get full text

Rare variants analyses suggest novel cleft genes in the African population by Alade, Azeez, Mossey, Peter, Awotoye, Waheed, Busch, Tamara, Oladayo, Abimbola M., Aladenika, Emmanuel, Olujitan, Mojisola, Wentworth, Emma, Anand, Deepti, Naicker, Thirona, Gowans, Lord J. J., Eshete, Mekonen A., Adeyemo, Wasiu L., Zeng, Erliang, Van Otterloo, Eric, O’Rorke, Michael, Adeyemo, Adebowale, Murray, Jeffrey C., Cotney, Justin, Lachke, Salil A., Romitti, Paul, Butali, Azeez

“…Non-syndromic orofacial clefts (NSOFCs) are common birth defects with a complex etiology. While over 60 common risk loci have been identified, they explain…”
Get full text

Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study by Herbach, Emma, O'Rorke, Michael A, Carnahan, Ryan M, McDowell, Bradley D, Allen, Bryan, Grumbach, Isabella, London, Barry, Smith, Brian J, Spitz, Douglas R, Seaman, Aaron, Chrischilles, Elizabeth A

“…Background We compared cardiac outcomes for surgery-eligible patients with stage III non-small-cell lung cancer treated adjuvantly or neoadjuvantly with…”
Get full text

Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients by Weeks, Kristin S., Lynch, Charles F., West, Michele M., Carnahan, Ryan M., O’Rorke, Michael A., Oleson, Jacob J., McDonald, Megan E., Charlton, Mary E.

“…National Comprehensive Cancer Network guidelines recommend ovarian cancer patients receive cancer-directed surgery from a gynecologic oncologist surgeon. We…”
Get full text

Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients by Weeks, Kristin S., Lynch, Charles F., West, Michele, Carnahan, Ryan, O'Rorke, Michael, Oleson, Jacob, McDonald, Megan, Stewart, Sherri L., Charlton, Mary

“…We aim to evaluate the impact gynecologic oncologists have on ovarian cancer adjuvant chemotherapy care from their role as surgeons recommending adjuvant…”
Get full text

Prior Autoimmune Disease and Risk of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Systematic Review by MCSHANE, Charlene M, MURRAY, Liam J, LANDGREN, Ola, O'RORKE, Michael A, KORDE, Neha, KUNZMANN, Andrew T, MOHAMMAD ROSHIDI ISMAIL, ANDERSON, Lesley A

“…Several observational studies have investigated autoimmune disease and subsequent risk of monoclonal gammopathy of undetermined significance (MGUS) and…”
Get full text

HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland by Anderson, Lesley A., O'Rorke, Michael A., Wilson, Robbie, Jamison, Jackie, Gavin, Anna T.

“…Assessment of Human papillomavirus (HPV) prevalence and genotype distribution is important for monitoring the impact of prophylactic HPV vaccination. This…”
Get full text

Built environment correlates of physical activity in low- and middle-income countries: A systematic review by Elshahat, Sarah, O'Rorke, Michael, Adlakha, Deepti

“…Insufficient physical activity (PA) is the fourth major risk factor for many non-communicable diseases and premature mortality worldwide. Features of the built…”
Get full text

The association between methods of biopsy and survival following breast cancer: A hospital registry based cohort study by Kong, Yek-Ching, Bhoo-Pathy, Nirmala, O’Rorke, Michael, Subramaniam, Shridevi, Bhoo-Pathy, Nanthini T., See, Mee-Hoong, Jamaris, Suniza, Teoh, Kean-Hooi, Bustam, Anita Z., Looi, Lai-Meng, Taib, Nur Aishah, Yip, Cheng-Har

“…Percutaneous biopsy in breast cancer has been associated with an increased risk of malignant cell seeding. However, the importance of these observations…”
Get full text

Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study by O'Rorke, Michael A., Cantwell, Marie M., Abnet, Christian C., Brockman, and John D., Murray, Liam J.

“…Trace elements have been cited as both inhibitory and causative agents of cancer but importantly exposure to them is potentially modifiable. Our study aimed to…”
Get full text

Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population‐based databases by Spence, Andrew D., Busby, John, Murchie, Peter, Kunzmann, Andrew T., McMenamin, Úna C., Coleman, Helen G., Johnston, Brian T., O'Rorke, Michael A., Murray, Liam J., Iversen, Lisa, Lee, Amanda J., Cardwell, Chris R.

“…Excessive lower oesophageal sphincter relaxation increases gastro‐oesophageal acid reflux, an oesophageal adenocarcinoma risk factor. Medications that relax…”
Get full text

Can physical activity modulate pancreatic cancer risk? a systematic review and meta‐analysis by O'Rorke, Michael A., Cantwell, Marie M., Cardwell, Chris R., Mulholland, Helen G., Murray, Liam J.

“…Numerous epidemiological studies have examined the association between physical activity and pancreatic cancer; however, findings from individual cohorts have…”
Get full text

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer by O’Rorke, Michael, Irwin, Gareth W., Kennedy, Richard D., Mullan, Paul B., McQuaid, Stephen, Salto-Tellez, Manuel, Buckley, Niamh E., Blayney, Jaine K., Parkes, Eileen E., Patel-Socha, Farah, James, Jacqueline, Cougot, Delphine, Bingham, Victoria, Hynes, Sean, Humphries, Matthew P., McArt, Darragh G.

“…The role of PD-L1 as a prognostic and predictive biomarker is an area of great interest. However, there is a lack of consensus on how to deliver PD-L1 as a…”
Get full text

Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients by Weeks, Kristin, Lynch, Charles F., West, Michele, Carnahan, Ryan, O'Rorke, Michael, Oleson, Jacob, McDonald, Megan, Stewart, Sherri L., Charlton, Mary

“…Up to one-third of women with ovarian cancer in the United States do not receive surgical care from a gynecologic oncologist specialist despite guideline…”
Get full text

Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers by Xu, Tao, Dillon, Joseph S., Maluccio, Mary A., Quelle, Dawn E., Nash, Sarah H., Cho, Hyunkeun, Limbach, Kristen E., Skill, Nicholas J., Bren-Mattison, Yvette, O’Rorke, Michael A.

“…Purpose Renal and hematological toxicity are side effects and dose-limiting factors of Peptide Receptor Radionuclide Therapy (PRRT). We aimed to assess the…”
Get full text

Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts by Cardwell, Chris R, Pottegård, Anton, Vaes, Evelien, Garmo, Hans, Murray, Liam J, Brown, Chris, Vissers, Pauline A J, O'Rorke, Michael, Visvanathan, Kala, Cronin-Fenton, Deirdre, De Schutter, Harlinde, Lambe, Mats, Powe, Des G, van Herk-Sukel, Myrthe P P, Gavin, Anna, Friis, Søren, Sharp, Linda, Bennett, Kathleen

“…Preclinical studies have demonstrated that propranolol inhibits several pathways involved in breast cancer progression and metastasis. We investigated whether…”
Get full text

Impact of surgeon type and rurality on treatment and survival of ovarian cancer patients by Weeks, Kristin, West, Michele, Carnahan, Ryan, O'Rorke, Michael, McDonald, Megan, Lynch, Chuck, Charlton, Mary

“…We aimed to determine if rurality impacts type of surgeon and estimate if the interaction between rurality and type of surgeon impacts cytoreductive surgery,…”
Get full text

Evaluation of a Worksite Cervical Screening Initiative to Increase Pap Smear Uptake in Malaysia: A Cluster Randomized Controlled Trial by Su, Tin Tin, Murray, L., O’Rorke, Michael, Abdullah, Fauziah

“…Background. Despite the significant burden of cervical cancer, Malaysia like many middle-income countries relies on opportunistic cervical screening as opposed…”
Get full text

Disparities in breast cancer stage at diagnosis between immigrant and native-born women: A meta-analysis by Herbach, Emma L., Weeks, Kristin S., O'Rorke, Michael, Novak, Nicole L., Schweizer, Marin L.

“…To synthesize existing observational evidence to identify disparities in stage at breast cancer diagnosis between foreign- and native-born women. We…”
Get full text